Pharma

By Heather Mack April 10, 2017
Online health network PatientsLikeMe is teaming up with rare disease-focused Shire Pharmaceuticals to develop digital communities and create research opportunities for people with highly specialized, often underserved conditions. Treatment and study of rare diseases is challenging for many reasons. For one, patient populations are small and spread out around the world, and many may not have...
By Jonah Comstock April 7, 2017
A forthcoming 28-patient study in the American Heart Association's journal Stroke shows that AiCure's artificial intelligence platform led to a 50 percent improvement in adherence to oral anticoagulants. In the study, a cohort of 28 ischemic stroke survivors was followed for 12 weeks. Fifteen were assigned to the intervention group that used AiCure's software to monitor their adherence daily, and...
By Jonah Comstock April 6, 2017
Two Minneapolis-based companies – digital health care management program maker HealthFactors and medical-focused R&D firm Koronis BioMedical Technologies (KBT) – are working together to create new smart inhaler products for some undisclosed pharmaceutical partners, the company announced earlier this week. “Connected health technology, including smart inhalers, has the ability to improve...
By Heather Mack April 6, 2017
There is a basic bodily function that all people have, yet most do not want to see, hear or smell – let alone talk about. But bowel movements are an important indicator of health, and for the estimated 33 million Americans living with Chronic Idiopathic Constipation (CIC), discussion about their bathroom business is critical to finding the right treatment plan, as well as politely communicating...
By Jonah Comstock April 6, 2017
Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared at the end of March, is called My Dose Coach. A pending trademark application gives a more in-depth description of the app, describing it as "downloadable software in the nature of a mobile...
By Heather Mack March 29, 2017
Many pharmaceutical companies are now turning to digital tools to improve medication adherence, augment clinical trials, or develop parallel therapies with digital health companies. Rare is the pharmaceutical company that wants to actively get people to stop taking their medication, but that’s exactly the aim of a new study launched by Purdue Pharmaceuticals, maker of the blockbuster and...
By Jonah Comstock March 27, 2017
Digital Pharmacist, a company formed in January from a merger of RxWiki and TeleManager, made its first acquisition last week: An app called PocketRx, made by Shreveport, Louisiana-based software development company Praeses. The terms of the acquisition were not disclosed. Robert Terrell, who invented the PocketRx app, joined RxWiki as director of product in December. His title at Digital...
By Jonah Comstock March 24, 2017
Sanofi Consumer Healthcare, a division of the global pharmaceutical company, used wearable devices in a "social experiment" that forms part of the marketing efforts for Xyzal, its 24-hour allergy medication that recently became available over the counter. The company used wearables to track the sleep and activity of allergy sufferers in a small non-scientific test in order to demonstrate ways in...
By Jonah Comstock March 20, 2017
Global pharmaceutical company UCB has launched Wellness4U, a health and wellness platform for people living with immunologic disorders which includes, as one aspect, an activity tracker pilot program. "Our medicines treat thousands of people around the world and we are engaging with patients, their families and healthcare professionals to address their unmet needs," Todd Edwards, vice president...
By Heather Mack March 17, 2017
The human brain and the seemingly infinite number of health complications that can befall it are complex. As such, there aren’t universally agreed-upon therapies and treatments for conditions ranging from depression and chronic pain to stroke and Parkinson’s disease. But recent, rapid advances in neuroscience research and digital technology are enabling a new wave of tools to gain traction in...

Editor's Pick